TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive Fewer, Larger RT Doses Cut Recurrence Of Early Breast Cancer, UK Study Finds June 29, 2007